Losing her hair at 59 — a stark, visible sign of her struggle with ovarian cancer – was a “distressing” time for Victoria ...
The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...
The oral contraceptive pills Yaz and Yasmin will be listed on the Pharmaceutical Benefits Scheme (PBS) from March 1 2025, ...
Cancer is a significant public health issue and economic burden, with breast cancer being the most prevalent among women in ...
LAS VEGAS ( KLAS) — A medical school student at the University of Nevada, Las Vegas is hoping to change the way restaurants ...
BuzzFeed on MSN1d
These 24 Doctors Ignored Female Patients, And You'll Be Shocked By Their Unbelievably Unprofessional Actions17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...
Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...
Results from the PEACOCC trial warrant further investigation into treatment with pembrolizumab in patients with previously ...
A guest column by Stan Gottfredson, CEO at Atraxia Law, a paralegal firm based in San Diego, California, that assists individuals affected by toxic exposure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback